Ali S. Omrani
Hamad Medical Corporation(QA)Qatar University(QA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Long-Term Effects of COVID-19
Most-Cited Works
- → Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study(2014)512 cited
- → Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia(2014)497 cited
- → Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection(2015)388 cited
- → COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)(2021)315 cited
- → Tocilizumab for the treatment of severe coronavirus disease 2019(2020)268 cited
- → Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction(2015)183 cited
- → A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case(2013)180 cited
- → Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis(2018)180 cited
- → Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?(2015)102 cited
- → Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review(2021)95 cited